tiprankstipranks
Bruker Corp (MX:BRKR)
:BRKR
Mexico Market
BRKR
Bruker
RESEARCH TOOLSreports

Bruker (BRKR) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

BRKR Analyst Ratings

Moderate Buy
9Ratings
Moderate Buy
5 Buy
3 Hold
1 Sell
Based on 9 analysts giving stock ratings to
Bruker
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BRKR Stock 12 Month Forecast

Average Price Target

$942.15
▲(33.64% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Bruker in the last 3 months. The average price target is $942.15 with a high forecast of $1,182.97 and a low forecast of $675.98. The average price target represents a 33.64% change from the last price of $705.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"611":"$611","754":"$754","897":"$897","1040":"$1,040","1183":"$1,183"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1182.9719636,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.18K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":942.1526710100001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$942.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":675.9839792,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$675.98</span>\n  </div></div>","useHTML":true}}],"tickPositions":[611,754,897,1040,1183],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,705,741.7670741230769,778.5341482461538,815.3012223692308,852.0682964923077,888.8353706153846,925.6024447384616,962.3695188615385,999.1365929846154,1035.9036671076924,1072.6707412307692,1109.4378153538462,1146.2048894769232,{"y":1182.9719636,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,705,723.2425131546154,741.4850263092308,759.7275394638461,777.9700526184615,796.2125657730769,814.4550789276923,832.6975920823077,850.940105236923,869.1826183915384,887.4251315461538,905.6676447007693,923.9101578553847,{"y":942.1526710100001,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,705,702.7679984,700.5359968,698.3039952,696.0719936,693.839992,691.6079904000001,689.3759888,687.1439872,684.9119856,682.679984,680.4479824,678.2159808,{"y":675.9839792,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":617.74,"date":1756674000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":612.675,"date":1759266000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":712.297,"date":1761948000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":702.335,"date":1764540000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":839.713,"date":1767218400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":839.713,"date":1769896800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":839.713,"date":1772316000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":704.134,"date":1774990800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":704.134,"date":1777582800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":704.134,"date":1780261200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":705,"date":1782853200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":705,"date":1785531600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":705,"date":1788210000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,183Average Price Target$942.15Lowest Price Target$675.98
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on MX:BRKR
Luke Sergott
Barclays
Barclays
$980.18
Buy
39.03%
Upside
Reiterated
08/25/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
J.P. Morgan Analyst forecast on MX:BRKR
Casey Woodring
J.P. Morgan
J.P. Morgan
$1,098.47→$1,013.98
Buy
43.83%
Upside
Reiterated
08/06/26
J.P. Morgan Remains a Buy on Bruker (BRKR)
Wells Fargo Analyst forecast on MX:BRKR
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$929.48
Buy
31.84%
Upside
Reiterated
08/05/26
Bruker (BRKR) Receives a Buy from Wells Fargo
Stifel Nicolaus Analyst forecast on MX:BRKR
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$760.48→$844.98
Hold
19.86%
Upside
Reiterated
08/05/26
Bruker price target raised to $50 from $45 at StifelBruker price target raised to $50 from $45 at Stifel
Bank of America Securities Analyst forecast on MX:BRKR
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
08/05/26
Analysts Are Bullish on These Healthcare Stocks: Bruker (BRKR), Arvinas Holding Company (ARVN)
Citi Analyst forecast on MX:BRKR
Patrick B Donnelly
Citi
Citi
$1,013.98→$895.68
Hold
27.05%
Upside
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Spyre Therapeutics (NASDAQ: SYRE), Ultragenyx Pharmaceutical (NASDAQ: RARE) and Bruker (NASDAQ: BRKR)
Guggenheim Analyst forecast on MX:BRKR
Subbu Nambi
Guggenheim
Guggenheim
$1,182.97
Buy
67.80%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on MX:BRKR
Kyle Boucher
TD Cowen
TD Cowen
$1,013.98
Hold
43.83%
Upside
Reiterated
08/04/26
Hold Rating Maintained on Bruker as Mixed End-Market Trends and Back-Half-Weighted Outlook Keep Risk/Reward Balanced
Goldman Sachs Analyst forecast on MX:BRKR
Evie Koslosky
Goldman Sachs
Goldman Sachs
$591.49→$675.98
Sell
-4.12%
Downside
Reiterated
07/27/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD), Bruker (NASDAQ: BRKR) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
Wolfe Research Analyst forecast on MX:BRKR
Michael Polark
Wolfe Research
Wolfe Research
―
Hold
―
Downgraded
06/01/26
Bruker assumed at Peer Perform from Outperform at Wolfe ResearchBruker assumed at Peer Perform from Outperform at Wolfe Research
RBC Capital Analyst forecast on MX:BRKR
Dan Leonard
RBC Capital
RBC Capital
$675.98→$760.48
Hold
7.87%
Upside
Assigned
05/07/26
Bruker price target raised to $45 from $40 at UBSBruker price target raised to $45 from $40 at UBS
Jefferies Analyst forecast on MX:BRKR
Tycho Peterson
Jefferies
Jefferies
$929.48→$844.98
Buy
19.86%
Upside
Reiterated
02/12/26
Bruker price target lowered to $50 from $55 at JefferiesBruker price target lowered to $50 from $55 at Jefferies
Rothschild & Co Redburn Analyst forecast on MX:BRKR
Natalya Davies
Rothschild & Co Redburn
Rothschild & Co Redburn
$1,013.98
Buy
43.83%
Upside
Reiterated
11/20/25
Bruker initiated with a Buy at Rothschild & Co RedburnBruker initiated with a Buy at Rothschild & Co Redburn
Nephron Analyst forecast on MX:BRKR
Jack Meehan
Nephron
Nephron
―
Hold
―
Upgraded
11/03/25
Bruker upgraded to Hold from Sell at Nephron ResearchBruker upgraded to Hold from Sell at Nephron Research
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on MX:BRKR
Luke Sergott
Barclays
Barclays
$980.18
Buy
39.03%
Upside
Reiterated
08/25/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
J.P. Morgan Analyst forecast on MX:BRKR
Casey Woodring
J.P. Morgan
J.P. Morgan
$1,098.47→$1,013.98
Buy
43.83%
Upside
Reiterated
08/06/26
J.P. Morgan Remains a Buy on Bruker (BRKR)
Wells Fargo Analyst forecast on MX:BRKR
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$929.48
Buy
31.84%
Upside
Reiterated
08/05/26
Bruker (BRKR) Receives a Buy from Wells Fargo
Stifel Nicolaus Analyst forecast on MX:BRKR
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$760.48→$844.98
Hold
19.86%
Upside
Reiterated
08/05/26
Bruker price target raised to $50 from $45 at StifelBruker price target raised to $50 from $45 at Stifel
Bank of America Securities Analyst forecast on MX:BRKR
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
08/05/26
Analysts Are Bullish on These Healthcare Stocks: Bruker (BRKR), Arvinas Holding Company (ARVN)
Citi Analyst forecast on MX:BRKR
Patrick B Donnelly
Citi
Citi
$1,013.98→$895.68
Hold
27.05%
Upside
Reiterated
08/05/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Spyre Therapeutics (NASDAQ: SYRE), Ultragenyx Pharmaceutical (NASDAQ: RARE) and Bruker (NASDAQ: BRKR)
Guggenheim Analyst forecast on MX:BRKR
Subbu Nambi
Guggenheim
Guggenheim
$1,182.97
Buy
67.80%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on MX:BRKR
Kyle Boucher
TD Cowen
TD Cowen
$1,013.98
Hold
43.83%
Upside
Reiterated
08/04/26
Hold Rating Maintained on Bruker as Mixed End-Market Trends and Back-Half-Weighted Outlook Keep Risk/Reward Balanced
Goldman Sachs Analyst forecast on MX:BRKR
Evie Koslosky
Goldman Sachs
Goldman Sachs
$591.49→$675.98
Sell
-4.12%
Downside
Reiterated
07/27/26
Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD), Bruker (NASDAQ: BRKR) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)
Wolfe Research Analyst forecast on MX:BRKR
Michael Polark
Wolfe Research
Wolfe Research
―
Hold
―
Downgraded
06/01/26
Bruker assumed at Peer Perform from Outperform at Wolfe ResearchBruker assumed at Peer Perform from Outperform at Wolfe Research
RBC Capital Analyst forecast on MX:BRKR
Dan Leonard
RBC Capital
RBC Capital
$675.98→$760.48
Hold
7.87%
Upside
Assigned
05/07/26
Bruker price target raised to $45 from $40 at UBSBruker price target raised to $45 from $40 at UBS
Jefferies Analyst forecast on MX:BRKR
Tycho Peterson
Jefferies
Jefferies
$929.48→$844.98
Buy
19.86%
Upside
Reiterated
02/12/26
Bruker price target lowered to $50 from $55 at JefferiesBruker price target lowered to $50 from $55 at Jefferies
Rothschild & Co Redburn Analyst forecast on MX:BRKR
Natalya Davies
Rothschild & Co Redburn
Rothschild & Co Redburn
$1,013.98
Buy
43.83%
Upside
Reiterated
11/20/25
Bruker initiated with a Buy at Rothschild & Co RedburnBruker initiated with a Buy at Rothschild & Co Redburn
Nephron Analyst forecast on MX:BRKR
Jack Meehan
Nephron
Nephron
―
Hold
―
Upgraded
11/03/25
Bruker upgraded to Hold from Sell at Nephron ResearchBruker upgraded to Hold from Sell at Nephron Research
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
SNDXSyndax Pharmaceuticals
PTGXProtagonist Therapeutics
ONCBeOne Medicines
HITIHigh Tide
IRTCIrhythm Technologies
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bruker

3 Months
Luke SergottBarclays
Success Rate
9/16 ratings generated profit
56%
Average Return
+2.12%
Copying Luke Sergott's trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +2.12% per trade.
1 Year
Luke SergottBarclays
Success Rate
12/16 ratings generated profit
75%
Average Return
+21.02%
Copying Luke Sergott's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +21.02% per trade.
2 Years
Luke SergottBarclays
Success Rate
14/16 ratings generated profit
88%
Average Return
+34.07%
Copying Luke Sergott's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +34.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BRKR Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
6
7
6
10
6
Hold
5
6
7
6
5
Sell
0
0
2
2
2
Strong Sell
0
0
0
0
0
total
11
13
15
18
13
In the current month, BRKR has received 6 Buy Ratings, 5 Hold Ratings, and 2 Sell Ratings. BRKR average Analyst price target in the past 3 months is 942.15.
Each month's total comprises the sum of three months' worth of ratings.

BRKR Financial Forecast

BRKR Earnings Forecast

Next quarter’s earnings estimate for BRKR is $7.14 with a range of $6.76 to $7.58. The previous quarter’s EPS was $8.29. BRKR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BRKR has Performed in-line its overall industry.
Next quarter’s earnings estimate for BRKR is $7.14 with a range of $6.76 to $7.58. The previous quarter’s EPS was $8.29. BRKR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BRKR has Performed in-line its overall industry.

BRKR Sales Forecast

Next quarter’s sales forecast for BRKR is $14.67B with a range of $14.52B to $14.78B. The previous quarter’s sales results were $14.18B. BRKR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BRKR has Performed in-line its overall industry.
Next quarter’s sales forecast for BRKR is $14.67B with a range of $14.52B to $14.78B. The previous quarter’s sales results were $14.18B. BRKR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BRKR has Performed in-line its overall industry.

BRKR Stock Forecast FAQ

What is MX:BRKR’s average 12-month price target, according to analysts?
Based on analyst ratings, Bruker Corp’s 12-month average price target is 942.15.
    What is MX:BRKR’s upside potential, based on the analysts’ average price target?
    Bruker Corp has 33.64% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Bruker Corp a Buy, Sell or Hold?
          Bruker Corp has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 3 hold ratings and 1 sell ratings.
            What is Bruker Corp’s share price target?
            The average share price target for Bruker Corp is 942.15. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $1,182.97 ,and the lowest forecast is $675.98. The average share price target represents 33.64% Increase from the current price of $705.
              What do analysts say about Bruker Corp?
              Bruker Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of Bruker Corp?
                To buy shares of MX:BRKR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.